Evidence map›Paper›PMID 40592877›Full record

ArticleScientific reports2025

Single nucleus RNA-seq reveals the process from onset to chronic kidney disease in IgA nephropathy.

Jun-Peng You, Gen-Yang Cheng, Xiao-Xue Zhang, Zheng Wang, Chen Liu, Wei Ning, Ya-Ru Liu, Hui-Miao Hu, Ya-Ling Zhai, Yuan-Yuan Qi and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jun-Peng YouDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Gen-Yang ChengDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Xiao-Xue ZhangDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Zheng WangDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Chen LiuDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Wei NingDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Ya-Ru LiuDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Hui-Miao HuDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Ya-Ling ZhaiDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China.
Yuan-Yuan QiDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China. qqyyiillyy@126.com.
Zhan-Zheng ZhaoDepartment of Nephrology, Nephrology Hospital, The First Affiliated Hospital of Zhengzhou University,Institute of Nephrology, Zhengzhou University, No.1, Jianshe Road, Erqi District, Zhengzhou, 450052, Henan, People's Republic of China. zhanzhengzhao@zzu.edu.cn.

Funding

National Natural Science Foundation of China 82470751National Natural Science Foundation of China 82470752Natural Science Foundation of Henan Province 242300421275
6 · The paper itself

Abstract

IgA nephropathy (IgAN) is a common form of glomerulonephritis. According to the established multi-hit theory of IgAN pathogenesis, the final hit is the mesangial deposition of IgA1-containing immune complexes, leading to characteristic pathological features such as mesangial cell proliferation and expansion of extracellular matrix. We analyzed several public transcriptomic datasets, including microarray and bulk RNA-sequencing, to identify pathway alterations in IgAN patients and progressors. We also generated our own single-nucleus RNA-sequencing dataset from IgAN kidney biopsies with normal or reduced estimated glomerular filtration rate and integrated it with a publicly available healthy control dataset to comprehensively examine cell type-specific changes during IgAN progression. Pathways related to complement activation, focal adhesion, and collagen formation were significantly enhanced in IgAN compared to healthy controls. Our snRNA-seq data identified two mesenchymal stromal cell (MSC) clusters with higher scores in these pathways than other cell types, which were progressively perturbed as eGFR declined. We observed a potential transition from mesangial cells to myofibroblasts within MSCs, accompanied by increased expression of genes involved in complement activation, humoral immunity, collagen organization, and extracellular matrix assembly. This transition could be partially reversed through in silico knockdown of certain transcription factors, such as PRRX1.

Indexed as

Glomerulonephritis, IGARenal Insufficiency, ChronicRNA-SeqAdultComplement ActivationDisease ProgressionFemaleGene Expression ProfilingHumansMaleMesangial CellsSequence Analysis, RNASingle-Cell AnalysisTranscriptomeChronic kidney diseaseIgA nephropathyMesangial cellsMesenchymal stromal cellsMyofibroblastsSingle nucleus RNA-seq

Identifiers

PMID40592877
PMCPMC12216285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.